April 21, 2015

Less than 1% of all pharmaceutical reports to American Association of Poison Control Centers associated with homeopathic medicines, the American Association of Homeopathic Pharmacists told the Food and Drug Administration.

April 21, 2015

Industry associations on Tuesday praised a House vote to pass Rep. Tom Marino's drug diversion bill.

April 20, 2015

DSN examines chain pharmacy — including in-depth coverage of provider status, generics, pharmacy deserts, point-of-care testing and more — in this multi-page report.

April 14, 2015

DSN editor in chief Rob Eder talks about why Congress needs to rethink current DEA regulations that block access to medications to chronic pain patients.


April 14, 2015

Taiwan-based drug development company Sunny Pharmtech and Vitruvias Therapeutics, a generic drug development company, on Tuesday announced that they will team up to co-develop a portfolio of generic drug products.

April 13, 2015

Wholesaler distributor H. D. Smith promoted Dmitrey Kuznetsov to SVP, category management.

April 13, 2015

Hi-Tech Pharmaceuticals on Monday acquired Mexican OTC and nutritional manufacturer Advanced Pharmaceuticals and Nutritionals. 

April 7, 2015

The disparity between reimbursement rates and generic drug costs caused by a lag in payment is forcing many community pharmacies to operate at a negative margin.

March 31, 2015

The director of the FDA’s Office of Generic Drugs temporarily steps down to deal with a medical issue, according to a report by the Regulatory Focus Professionals Society.

March 27, 2015

The Food and Drug Adminisration on Friday revisited the issue of supplemental applications proposing labeling changes for approved drugs and biologic products. 

March 17, 2015

A new Harris Poll reveals some surprise findings on Americans' preference for generic or branded drugs.

March 16, 2015

The letter to the editor emphasized the need for a comprehensive approach to curbing prescription drug abuse and diversion.

March 13, 2015

How do the nation’s pharmacists rate with Americans? According to Gallup, the answer is very, very high year after year.

March 13, 2015

Thank you to the 114th Congress for welcoming the participants in the 2015 NACDS RxIMPACT Day on Capitol Hill! We appreciate the opportunity to meet with you and discuss the key policy issues that shape pharmacy patient care for your constituents.

March 10, 2015

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

March 10, 2015

Impax Labs completed its acquisition of Tower Holdings (which includes operating subsidiaries CorePharma and Amedra Pharmaceuticals), and Lineage Therapeutics. Impax also announced that it would reshape both the operating and reporting structure of its two divisions.

March 9, 2015

DSN examines chain pharmacy, including in-depth coverage of provider status, kiosks, Medicare and the GPhA elections, in this multi-page report.

March 5, 2015

CHPA announced its strong support for the Restoring Access to Medicines Act of 2015 (H.R. 1270).

March 4, 2015

In preparation for the Consumer Healthcare Products Association’s 2015 Annual Executive Conference being held in Bonita Springs, Fla., this month, Drug Store News sat down with both Scott Melville, CHPA president and CEO, and Patrick Lockwood-Taylor, CHPA chair and VP personal health care, North America, for Procter & Gamble.

February 26, 2015

Congress introdues legislation to protect FDA user fees from sequestration. 

February 24, 2015

The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change. 

February 20, 2015

The recently introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2015 receives support from the National Association of Chain Drug Stores.

February 19, 2015

IRI and Kline & Co. establish an exclusive alliance to provide clients with a greater level of actionable insights.

February 17, 2015

The Food and Drug Administration last week issued five draft documents related to drug compounding and repackaging that will help entities comply with important public health provisions.